SC79 attenuates dexamethasone (Dex)-induced osteoblast cell death.
SC79 attenuates Dex-induced both apoptosis and programmed necrosis in osteoblasts.
Activation of Akt is required for SC79-mediated cytoprotection against Dex in osteoblasts.
SC79 activates Akt downstream Nrf2 signaling to inhibit Dex-induced oxidative stress.